Maitreya Medicare Ltd
Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]
- Market Cap ₹ 166 Cr.
- Current Price ₹ 245
- High / Low ₹ 360 / 214
- Stock P/E 1,038
- Book Value ₹ 46.4
- Dividend Yield 0.00 %
- ROCE 10.8 %
- ROE 7.17 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 55.93 | 49.35 | 39.28 | 46.08 | 44.98 | 46.00 | |
| 48.68 | 45.98 | 32.02 | 40.08 | 40.10 | 43.28 | |
| Operating Profit | 7.25 | 3.37 | 7.26 | 6.00 | 4.88 | 2.72 |
| OPM % | 12.96% | 6.83% | 18.48% | 13.02% | 10.85% | 5.91% |
| 0.43 | 0.33 | 0.53 | 0.30 | 0.57 | 0.63 | |
| Interest | 0.82 | 0.78 | 0.57 | 0.84 | 0.80 | 0.78 |
| Depreciation | 1.09 | 1.32 | 1.29 | 1.27 | 1.44 | 1.57 |
| Profit before tax | 5.77 | 1.60 | 5.93 | 4.19 | 3.21 | 1.00 |
| Tax % | 26.52% | 28.75% | 28.16% | 29.12% | 41.74% | |
| 4.24 | 1.14 | 4.25 | 2.97 | 1.87 | 0.16 | |
| EPS in Rs | 4,240.00 | 1,140.00 | 8.57 | 4.38 | 2.76 | 0.24 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -3% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| TTM: | -91% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 18% |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 4.96 | 6.78 | 6.78 | 11.55 |
| Reserves | 3.85 | 4.70 | 3.81 | 18.07 | 19.94 | 19.91 |
| 14.24 | 12.38 | 11.59 | 11.10 | 10.53 | 4.28 | |
| 7.17 | 7.40 | 8.55 | 7.91 | 10.75 | 13.48 | |
| Total Liabilities | 25.27 | 24.49 | 28.91 | 43.86 | 48.00 | 49.22 |
| 13.84 | 13.40 | 11.60 | 14.32 | 15.26 | 16.31 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.07 | 0.32 | 0.68 | 1.47 | 0.04 | 0.04 |
| 10.36 | 10.77 | 16.63 | 28.07 | 32.70 | 32.87 | |
| Total Assets | 25.27 | 24.49 | 28.91 | 43.86 | 48.00 | 49.22 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 4.45 | 0.08 | 2.59 | -2.50 | 5.06 | |
| -5.07 | -0.02 | 0.36 | -5.44 | -7.37 | |
| 2.16 | -1.86 | -1.59 | 12.21 | 3.67 | |
| Net Cash Flow | 1.55 | -1.80 | 1.36 | 4.27 | 1.36 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 31.91 | 43.42 | 90.41 | 108.52 | 121.40 |
| Inventory Days | 68.78 | 40.82 | 69.86 | 40.26 | 36.56 |
| Days Payable | 258.06 | 221.84 | 319.59 | 207.25 | 199.54 |
| Cash Conversion Cycle | -157.37 | -137.61 | -159.32 | -58.47 | -41.58 |
| Working Capital Days | -4.11 | 3.11 | 43.12 | 73.43 | 73.68 |
| ROCE % | 12.33% | 32.85% | 17.30% | 10.77% |
Documents
Announcements
-
Agreements
5 December 2025 - 05-Dec-2025: Acquired property in Valsad, Gujarat to set up multi-specialty hospital; operated by wholly-owned subsidiary.
-
Investor Presentation
16 November 2025 - Investor presentation (Nov 2025): PAT negative after one-time Rs.1.70 Cr bad debt; expansion, new cath lab, Valsad unit.
-
Statement of deviation(s) or variation(s) under Reg. 32
15 November 2025 - No deviation in utilisation of Rs.1489.12 lakh IPO proceeds for HY ended Sep 30, 2025.
-
Outcome of Board Meeting
15 November 2025 - Board approved standalone and consolidated unaudited H1 results for Sept 30, 2025; limited review report Nov 14, 2025.
-
Related Party Transactions
8 October 2025 - Maitreya Medicare (SME) declares Regulation 23(9) related-party disclosure not applicable (Reg 15(2)); dated 08/10/2025.
Annual reports
Concalls
-
Nov 2025TranscriptAI SummaryPPT
-
Sep 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT
Integrated Healthcare Provider[1] Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.